From October 28, 2021 to February 10, 2022, the company has repurchased 883,300 shares, representing 1.13% for ¥7,999.54 million. With this, the company has completed the repurchase of 883,300 shares, representing 1.13% for ¥7,999.54 million under the buyback announced on October 28, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,614 JPY | +0.23% | -1.89% | -17.33% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.32% | 2.66B | |
+14.17% | 396B | |
+12.76% | 143B | |
+18.42% | 77.23B | |
-12.61% | 65.65B | |
-10.33% | 48.32B | |
-7.57% | 39.2B | |
+7.11% | 35.21B | |
+11.84% | 18.31B | |
+14.87% | 15.95B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.